Direct Meds vs TeleCareSpot
Two GLP-1 desks, one scoreboard. We put Direct Meds and TeleCareSpot head-to-head on the published Brief Score — the same six factors, scored the same way.
Direct Meds
FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.
TeleCareSpot
The verdict
TeleCareSpot takes this head-to-head.
TeleCareSpot scores 85 to 82 on our six-factor Brief Score — A nationwide desk with an oral option — full-formulary, but priced at the premium end.
That doesn't make Direct Meds a bad call — it's best for readers who want a needle-free oral or sublingual route on either molecule and an all-inclusive price with no separate membership — and who are comfortable that the figures are company-stated rather than checkout-verified. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Direct Meds | TeleCareSpot | |
|---|---|---|
| Brief Score | 82/100 (B−) | 85/100 (B) |
| Semaglutide | $249/mo sublingual · $297/mo injectable | $299/mo |
| Tirzepatide | $299/mo sublingual · $399/mo injectable | $399/mo |
| Coverage | Not publicly listed | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
Direct Meds: Company-stated rates unchanged this cycle — but we price these off the desk's own listings, not a live-verified checkout, so treat them as indicative.
TeleCareSpot: $299 sema / $399 tirz nationwide, with an oral route.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.